| Metric | Q2 2022 | Q1 2022 | Q2 2021 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.3B | $1.2B | 5.6% | 20.7% |
| Op. Income | $488M | $506M | $330M | -3.5% | 47.7% |
| Gross Margin | 75.0% | 78.3% | 76.5% | -3.3pp | -1.5pp |
| Net Margin | 23.6% | 25.5% | 17.4% | -1.9pp | 6.2pp |
| EPS (Diluted) | $4.07 | $2.40 | $2.54 | 69.5% | 60.3% |
| Free Cash Flow | -$145M | -$306M | $261M | 52.6% | -155.6% |
| Item | Amount |
|---|---|
| REVENUE | $1.4B |
| Cost of Revenue | $352M |
| GROSS PROFIT | $1.1B |
| R&D Expenses | $0 |
| Selling & Marketing | $45M |
| General & Administrative | $405M |
| SG&A Expenses | $450M |
| Other Expenses | $115M |
| Operating Expenses | $565M |
| Cost & Expenses | $917M |
| OPERATING INCOME | $488M |
| Interest Income | $1.0B |
| Interest Expense | $246M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $488M |
| Income Tax Expense | $149M |
| NET INCOME | $331M |
| D&A | $45M |
| EBIT | $488M |
| EBITDA | $533M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| REVENUE | $1.4B |
| Cost of Revenue | $352M |
| GROSS PROFIT | $1.1B |
| R&D Expenses | $0 |
| Selling & Marketing | $45M |
| General & Administrative | $405M |
| SG&A Expenses | $450M |
| Other Expenses | $115M |
| Operating Expenses | $565M |
| Cost & Expenses | $917M |
| OPERATING INCOME | $488M |
| Interest Income | $1.0B |
| Interest Expense | $246M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $488M |
| Income Tax Expense | $149M |
| NET INCOME | $331M |
| D&A | $45M |
| EBIT | $488M |
| EBITDA | $533M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| Net Income | $331M |
| Depreciation & Amortization | $49M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$196M |
| Change in Working Capital | -$329M |
| OPERATING CASH FLOW | -$145M |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $633M |
| NET CASH FROM INVESTING | $633M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$346M |
| Other Financing Activities | -$1.7B |
| NET CASH FROM FINANCING | -$2.1B |
| FREE CASH FLOW | -$145M |
| Net Change in Cash | -$1.6B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $8.9B |
| Short-Term Investments | $9.5B |
| Net Receivables | $320M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $18.8B |
| PP&E (Net) | $532M |
| Goodwill | $232M |
| Intangible Assets | $558M |
| Long-Term Investments | $47.5B |
| Tax Assets | $0 |
| Other Non-Current Assets | $853M |
| TOTAL NON-CURRENT ASSETS | $49.7B |
| TOTAL ASSETS | $68.5B |
| Account Payables | $252M |
| Short-Term Debt | $5.3B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $42.6B |
| TOTAL CURRENT LIABILITIES | $48.1B |
| Long-Term Debt | $6.7B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $6.0B |
| TOTAL NON-CURRENT LIABILITIES | $12.7B |
| TOTAL LIABILITIES | $60.8B |
| Common Stock | $382M |
| Additional Paid-In Capital | $67M |
| Retained Earnings | $1.0B |
| Treasury Stock | -$60M |
| Accum. Other Comp. Income | -$318M |
| Other Equity | $6.5B |
| TOTAL STOCKHOLDERS' EQUITY | $7.6B |
| Minority Interest | $158M |
| TOTAL EQUITY | $7.7B |
| TOTAL LIABILITIES & EQUITY | $68.5B |
| Total Debt | $11.9B |
| Net Debt | $3.0B |
